SARAJEVO (Bosnia and Herzegovina), December 27 (SeeNews) – Luxembourg-based Haden as failed to sell its remaining 15.95% stake in Bosnian drug maker Bosnalijek [SAJ:BSNLR] at an extraordinary auction on the Sarajevo Stock Exchange (SASE) earlier this week, bourse data showed.
The auction was scheduled for December 26, with Haden offering for sale 1,354,740 Bosnalijek shares at 18.85 marka ($10.8/9.6 euro) each, data from SASE's website showed.
You can subscribe to our M&A newsletter here
Last week, Haden managed to sell part of its holdings, representing some 10% of Bosnalijek's share capital, for 17 million marka at an auction on SASE, with 903,769 Bosnalijek shares changing hands at 18.85 marka. to 15.95% from 25.95%, according to December 27 bourse data.
As a result of last week's sale, Raiffeisen Bank Bosnia and Herzegovina's stake in Bosnalijek rose to 11.34% from 1.34%, while Haden's stake shrank to 15.95% from 25.95%, according to December 27 bourse data.
Thus, the largest single shareholder in Bosnalijek became KBC Euro Credit Capital with 23.67%, followed by Haden, Raiffeisen Bank, and Libya's Economic and Social Development Fund with 7.60%, bourse data showed. The remainder belongs to smaller shareholders.
Bosnalijek shares closed down 3.46% at 18.04 marka on SASE on Friday.
(1 euro = 1.95583 marka)